Nine Point Two Capital LLC Bridge Bio Pharma, Inc. Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Nine Point Two Capital LLC holds 8,442 shares of BBIO stock, worth $317,334. This represents 0.14% of its overall portfolio holdings.
Number of Shares
8,442
Previous 8,442
-0.0%
Holding current value
$317,334
Previous $222,000
53.15%
% of portfolio
0.14%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding BBIO
# of Institutions
294Shares Held
170MCall Options Held
10.4MPut Options Held
2.36M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$950 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$944 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$534 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$468 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$228 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.57B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...